SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE.X is trending as community members discuss recent price action and potential resistance levels, with some suggesting it's a good time to accumulate. There is also discussion around PEPE's position relative to other meme coins and its potential for a significant rally. Some users are comparing it to other meme coins like SHIB.X, while others are considering newer Solana-based coins.

"What's Updog?" is a Community Led token.

UpDog

$UPDOG.X, a Solana-based meme token, is gaining attention as the community rallies around its 'UpTober' theme and close-knit holder base. Active discussions revolve around its unique 'dad joke' meta and comparisons to other dog-themed cryptos. Community members highlight its presence on the Jupiter Strict List as a positive signal.

The national debt has increased every year for the past ten years, and interest expenses have remained fairly stable due to low interest rates and the perceived low risk of U.S. government default, according to the U.S. Treasury Fiscal Data. This coin is a parody coin about the debt crises in the US and to highlight various aspects about this crises in a humouros way to the people on solana. $USNDC

UnitedStates National Debt Coin

UnitedStates National Debt Coin ($USNDC.X) is gaining traction, with community members highlighting increased buzz and 'early-meme vibes.' Conversations revolve around potential for explosive growth, often mentioning tracking the coin's activity via Phantom wallet and its position within the Solana ecosystem. Some users are advising caution due to the team's involvement with a previous coin.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is trending as a community-driven token inspired by Grok's AI and Elon Musk's vision. Community members emphasize the project's transparency, burned liquidity, and direct connection to AI development, fueling excitement around its potential within the crypto meme coin space.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending amid discussions about meme coin season and comparisons to other dog-themed tokens like $UPDOG.X and $DOGE.X. Community members are debating its potential for significant gains, with some expressing concerns about its burn rate and others pointing to on-chain buybacks.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is currently trending amidst community discussions around potential price movements and accumulation strategies, with some anticipating a bullish breakout while others express skepticism. The launch of Algoland, an onchain adventure by the Algorand Foundation, has sparked both excitement and criticism within the community. Broader conversations involve Algorand's role in tokenizing real-world assets and its potential as a leader in the crypto space.

Hang Feng Technology Innovation Co Ltd.

Hang Feng Technology Innovation Co Ltd

FOFO is trending due to its recent explosive price action and high volume, reminiscent of past high-momentum stocks. The community is discussing its potential as a "pump and dump", comparing it to other Chinese IPOs, and debating whether to chase the rally or wait for a pullback. Some are also highlighting its low float and the fear of missing out (FOMO) as potential drivers.

Linea is the Layer 2 built from first principles to strengthen Ethereum and the entire ETH economy. Every aspect of its design—from its productive ETH burn mechanics, and capital efficient native yield, to its underlying Ethereum-equivalent zk tech—amplifies the value and utility of Ethereum Mainnet. All of this is backed by the largest ecosystem fund in the space, managed by the most trusted Ethereum builders. With institutional-grade infrastructure, and deep integration across DeFi, Linea is the best chain for ETH capital, where every transaction and every block strengthens Ethereum. Linea is where Ethereum wins.

Linea

Linea is trending as the community discusses its potential use by SWIFT for stablecoin payment tests, which is seen as a major validation of blockchain technology. Bullish sentiment is fueled by the possible implications for the Ethereum ecosystem, particularly regarding scalability and efficiency in financial operations. Some users are speculating about potential price increases and comparing Linea favorably to other cryptocurrencies.

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BioAffinity Technologies Inc

BioAffinity Technologies ($BIAF) is trending due to positive case studies demonstrating the effectiveness of its CyPath Lung test for early lung cancer detection, potentially reducing unnecessary biopsies; this news has sparked significant trading volume. The community is actively discussing the stock's potential for a breakout and a potential buyout, as well as its low float and high short interest, which could lead to a squeeze. Some traders are highlighting the company's potential in the lung cancer detection market.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding is trending as investors discuss the potential implications of its recent $150M investment in blockchain/AI platform Datavault (DVLT), funded with Bitcoin. The community is debating whether this move, along with a minority stake sale in Semnur, sets the stage for a major announcement, possibly a large dividend or strategic sale. Some believe shorts are trapped across biotech, AI, and blockchain, while others question the investment's value and its impact on Scilex's core operations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi

Iovance shares plunge after Q2 miss and voluntary withdrawal of Amtagvi's EU filing, despite strong U.S. sales growth for the therapy.

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade

The mean of analysts' price targets for Genmab (GMAB) points to a 33.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View

Novavax tops Q2 estimates and lifts 2025 sales forecast as Sanofi takes over global rollout of its COVID vaccine.

Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut

PRGO tops Q2 EPS but misses revenue; trims 2025 sales outlook, sending shares down in pre-market.

JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut

Jazz shares slide as Q2 loss widens on Chimerix charge, with 2025 sales outlook trimmed despite higher EPS guidance.

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption

CRISPR Therapeutics posts a wider second-quarter loss tied to Sirius deal costs, while Casgevy adoption gains momentum across global markets.

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View

BMRN's Q2 earnings surge 50% on strong Voxzogo and enzyme therapy sales, prompting a raised 2025 revenue and EPS outlook.

Sarepta to Report Q2 Earnings: What's in Store for the Stock?

SRPT's Q2 report, set to arrive Aug. 6, is likely to have Elevidys updates, restructuring plans and sales outlook in sharp investor focus.

Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?

TECH eyes modest Q4 growth as strong reagent and instrumentation demand offsets NIH and tariff concerns.

GMAB vs. ACAD: Which Stock Is the Better Value Option?

Genmab A/S is an international biotechnology company, which engages in the development of human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline includes daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma, teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease, and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel on June 11, 1998, and is headquartered in Copenhagen, Denmark.

GMAB
GENMAB A/S

Latest GMAB News

GMAB GENMAB A/S

Latest GMAB News

GMAB
GENMAB A/S